By Deployment
By Application
By End-use
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Artificial Intelligence In Epidemiology Market Snapshot
Chapter 4. Global Artificial Intelligence In Epidemiology Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Deployment Type Estimates & Trend Analysis
5.1. by Deployment Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Deployment Type:
5.2.1. On-premise
5.2.2. Cloud-based
5.2.3. Web-based
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
6.2.1. Infection Prediction and Forecasting
6.2.2. Disease and Syndromic Surveillance
Chapter 7. Market Segmentation 3: by End-use Estimates & Trend Analysis
7.1. by End-use & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-use:
7.2.1. Government and State Agencies
7.2.2. Research Labs
7.2.3. Pharmaceutical and Biotechnology Companies
7.2.4. Healthcare Providers
Chapter 8. Artificial Intelligence In Epidemiology Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Artificial Intelligence In Epidemiology Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2021-2034
8.1.2. North America Artificial Intelligence In Epidemiology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.1.3. North America Artificial Intelligence In Epidemiology Market revenue (US$ Million) by End-use, 2021-2034
8.1.4. North America Artificial Intelligence In Epidemiology Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Artificial Intelligence In Epidemiology Market revenue (US$ Million) by Deployment Type, 2021-2034
8.2.2. Europe Artificial Intelligence In Epidemiology Market revenue (US$ Million) by Application, 2021-2034
8.2.3. Europe Artificial Intelligence In Epidemiology Market revenue (US$ Million) by End-use, 2021-2034
8.2.4. Europe Artificial Intelligence In Epidemiology Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Artificial Intelligence In Epidemiology Market revenue (US$ Million) by Deployment Type, 2021-2034
8.3.2. Asia Pacific Artificial Intelligence In Epidemiology Market revenue (US$ Million) by Application, 2021-2034
8.3.3. Asia-Pacific Artificial Intelligence In Epidemiology Market revenue (US$ Million) by End-use, 2021-2034
8.3.4. Asia Pacific Artificial Intelligence In Epidemiology Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Artificial Intelligence In Epidemiology Market revenue (US$ Million) by Deployment Type, 2021-2034
8.4.2. Latin America Artificial Intelligence In Epidemiology Market revenue (US$ Million) by Application, 2021-2034
8.4.3. Latin America Artificial Intelligence In Epidemiology Market revenue (US$ Million) by End-use, 2021-2034
8.4.4. Latin America Artificial Intelligence In Epidemiology Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Artificial Intelligence In Epidemiology Market revenue (US$ Million) by Deployment Type, 2021-2034
8.5.2. Middle East & Africa Artificial Intelligence In Epidemiology Market revenue (US$ Million) by Application, 2021-2034
8.5.3. Middle East & Africa Artificial Intelligence In Epidemiology Market revenue (US$ Million) by End-use, 2021-2034
8.5.4. Middle East & Africa Artificial Intelligence In Epidemiology Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Cognizant Technology Solutions Corporation
9.2.2. Cerner Corporation (Oracle)
9.2.3. Epic Systems Corporation
9.2.4. eClinicalWorks LLC
9.2.5. Alphabet Inc.
9.2.6. Komodo Health
9.2.7. Microsoft Corporation
9.2.8. Meditech
9.2.9. Predixion Software
9.2.10. Siemens Healthineers AG
9.2.11. Intel Corporation
9.2.12. Bayer Healthcare
9.2.13. Artificial Intelligence for Medical Epidemiology (AIME)
9.2.14. Cardiolyse
9.2.15. SAS Institute, Inc.
9.2.16. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.